VEA
DXCM icon

Virtus ETF Advisers’s DexCom DXCM Stock Holding History

Virtus ETF Advisers’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-6,294
Closed -$714K – 466
2024
Q2 		$714K Buy
6,294
+337
+6% +$42.6K 0.35% 170
2024
Q1 		$826K Buy
+5,957
New +$749K 0.44% 73
2023
Q3 		– Sell
-6,328
Closed -$813K – 447
2023
Q2 		$813K Sell
6,328
-2,013
-24% -$243K 0.48% 54
2023
Q1 		$969K Buy
+8,341
New +$934K 0.53% 26
2022
Q3 		– Sell
-6,365
Closed -$474K – 449
2022
Q2 		$474K Buy
+6,365
New +$581K 0.18% 232
2019
Q4 		– Sell
-640
Closed -$24K – 471
2019
Q3 		$24K Sell
640
-136
-18% -$5.28K ﹤0.01% 334
2019
Q2 		$29K Buy
+776
New +$24.4K 0.01% 323

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Virtus ETF Advisers's DXCM Position: Q3 2024 in Review

Virtus ETF Advisers sold out of DexCom (DXCM) in Q3 2024, closing a stake of 6,294 shares — an estimated $714K sold.

Virtus ETF Advisers first reported a position in DXCM in Q2 2019 and held it in 7 quarters. The position peaked at $969K in Q1 2023. 889 funds tracked by Wall St. Rank hold DXCM as of Q3 2024.

  • Virtus ETF Advisers reported no remaining DexCom position as of Q3 2024 after selling out during the quarter.
  • Virtus ETF Advisers sold 6,294 DexCom shares in Q3 2024, an estimated $714K.
  • Virtus ETF Advisers first reported a position in DexCom in Q2 2019 and held it in 7 quarters.
  • Virtus ETF Advisers's DexCom position peaked at $969K in Q1 2023.
  • 889 funds tracked by Wall St. Rank held DexCom as of Q3 2024.

Based on Virtus ETF Advisers's 13F filing for Q3 2024, filed 14 Nov 2024.